Muscular Dystrophy news from FierceBiotech
NewsPTC124 proves promising in cystic fibrosis trial
PTC Therapeutics' PTC124 proved promising in an early stage cystic fibrosis trial in Israel. PTC124 has already spurred tremendous interest as a therapy for Duchenne muscular dystrophy. And the Read more...
PTC sued by an angry parent in search of PTC124
PTC Therapeutics has been on a roll over the last few months. But the biotech hit a loud bump when the New York Times featured the story of one mother's legal fight to gain access to PTC124 for her Read more...
| Press ReleasesPRESS RELEASE: Researchers Reverse Key Symptom of Muscular Dystrophy Researchers Reverse Key Symptom of Muscular Dystrophy Researchers at the University of Rochester Medical Center (URMC) have identified a compound that eliminates myotonia – a symptom of muscular Read more... |
Get more Muscular Dystrophy coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets